BRPI0917668A2 -
antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain
- Google Patents
antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain
Info
Publication number
BRPI0917668A2
BRPI0917668A2BRPI0917668ABRPI0917668ABRPI0917668A2BR PI0917668 A2BRPI0917668 A2BR PI0917668A2BR PI0917668 ABRPI0917668 ABR PI0917668ABR PI0917668 ABRPI0917668 ABR PI0917668ABR PI0917668 A2BRPI0917668 A2BR PI0917668A2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008904178Aexternal-prioritypatent/AU2008904178A0/en
Application filed by Cephalon Australia Pty LtdfiledCriticalCephalon Australia Pty Ltd
Priority claimed from PCT/AU2009/001047external-prioritypatent/WO2010017598A1/en
Publication of BRPI0917668A2publicationCriticalpatent/BRPI0917668A2/en
BRPI0917668A2008-08-142009-08-14
antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain
BRPI0917668A2
(en)
antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain
isolated monoclonal antibody, isolated nucleic acid molecule, host cell, method for producing an isolated monoclonal antibody, pharmaceutical composition, and use of the composition
isolated binding member, use of an isolated binding member, method for treating a disorder, isolated nucleic acid molecule, host cell, and method for producing a binding member
Humanized antibody or binding fragment thereof, isolated nucleic acid, vector, host cell, method for producing a humanized antibody or binding fragment thereof, composition, method for treating a vwf-mediated disease or disorder in an individual, use of a humanized antibody or binding fragment thereof, method for administering the humanized antibody or binding fragment thereof, article of manufacture and kit
Humanized antibodies and antibody fragments that specifically bind sphingosine-1-phosphate, nucleic acids encoding the same and compositions and methods for use thereof to treat disease
Compound, process for preparing a compound, use of a compound, method for treating a disease or condition, pharmaceutical composition, process for preparing a pharmaceutical composition, product, and kit.
isolated antibody or antigen-binding fragment of the same, isolated nucleic acid, vector, host cell, pharmaceutical composition, method of producing said antibody or fragment, use thereof, and composition comprising said antibody or fragment
compound, use of a compound, methods for producing an antiproliferative effect on a warm-blooded animal, and for treating disease, and, pharmaceutical composition
Anti-hepcidin antibodies and uses thereof, polynucleotide, recombinant expression vector, process for producing an antibody, pharmaceutical composition, immunoassay and kit for carrying it out
ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME
Legal Events
Date
Code
Title
Description
B08F
Application fees: dismissal - article 86 of industrial property law
B08K
Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)
Free format text:
EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.